Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure.
Alginate-polylysine microencapsulation has been proposed as a method of protecting transplanted pancreatic islets against immunological attack. Using this technique, prolonged graft survival has been reported in some diabetic animals. However, in the spontaneously diabetic insulin-dependent BB/E rat we found that intraperitoneal implantation of microencapsulated islets had only a short-lived effect on hyperglycaemia. Recovered microcapsules (both those implanted empty and containing islets) were surrounded by a foreign body type cellular overgrowth and, although many capsules remained intact, encapsulated islets were observed to be disintegrating. Loss of Beta cells was confirmed by immunohistology. Various polymer materials used in artificial membranes have been shown to activate macrophages involved in foreign body reactions and induce synthesis of interleukin-1 beta, a known Beta-cell toxin. Reduced secretion of insulin and progressive islet damage (indicated by a significant reduction in residual islet insulin and DNA content) were demonstrated when microencapsulated islets were incubated with interleukin-1 beta in vitro for 9 days. Similar effects were seen following exposure to a combination of gamma interferon and alpha tumour necrosis factor. Successful use of microencapsulation in islet transplantation depends upon the development of biocompatible membranes. The exclusion of smaller molecules, such as cytokines, which may be involved in foreign body mediated damage and microencapsulated islet graft rejection, could also be important.
Cole
D R
DR
University of Edinburgh Department of Medicine, UK.
Waterfall
M
M
McIntyre
M
M
Baird
J D
JD
D000464:Alginates; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D046508:Culture Techniques / Q000379:methods; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000601:surgery*; D005947:Glucose / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D016381:Islets of Langerhans Transplantation / Q000473:pathology / Q000502:physiology*; D008297:Male; D008567:Membranes, Artificial; D011107:Polylysine / Q000031:analogs & derivatives; D051381:Rats; D011913:Rats, Inbred BB; D011920:Rats, Inbred WF
D000464:Alginates; D001786:Blood Glucose; D007328:Insulin; D008567:Membranes, Artificial; C051546:alginate-polylysine-alginate; D011107:Polylysine; D005947:Glucose